Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology Scientific and Clinical Aspects of Anemia in Cancer /

Anemia is a frequent complication of cancer and its treatment. It produces many symptoms and significantly impairs metabolic and physiologic functions as well as patients' activity, well-being and quality of life. Life expectancy is also affected. This book, now being published in its second ed...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Nowrousian, Mohammad Resa (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Vienna : Springer Vienna, 2008.
Έκδοση:Second, Revised and Enlarged Edition.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
Πίνακας περιεχομένων:
  • Physiology of erythropoiesis
  • Biology of EPO and EPO-receptor
  • The role of erythropoietin receptor expression on tumor cells
  • Problems associated with erythropoietin receptor determination on tumor cells
  • Definition, classification and characterization of anemia in cancer
  • Pathophysiology of anemia in cancer
  • Prevalence and incidence of anemia and risk factors for anemia in patients with cancer
  • Significance of anemia in cancer chemotherapy
  • Incidence and impact of anemia in radiation oncology
  • Relationship between hemoglobin levels and tumor oxygenation
  • Tumor hypoxia and therapeutic resistance
  • Symptoms of anemia
  • Impact of anemia and red blood cell transfusion on organ function
  • Relationship of hemoglobin, fatigue, and quality of life in anemic cancer patients
  • When to use red blood cell transfusions in cancer patients with solid tumours?
  • Pharmacology, pharmacokinetics and safety of recombinant human erythropoietin preparations
  • Epoetin treatment of anemia associated with multiple myeloma and non-Hodgkin’s lymphoma
  • rhEPO in anemic patients with solid tumors and chemotherapy — efficacy and safety
  • Early intervention with recombinant human erythropoietin for chemotherapy-induced anemia
  • Recombinant human erythropoietin (rhEPO) therapy in myelodysplasia
  • Prediction of response to rhEPO in the anemia of cancer
  • rhEPO in hematopoietic stem cell transplantation
  • Treatment of anemia with rhEPO in radiation oncology
  • Recombinant human erythropoietin in pediatric oncology
  • rhEPO in surgical oncology
  • Erythropoiesis, iron metabolism and iron supplementation during erythropoietin therapy
  • Are there risks for use of iron in cancer patients?
  • Metabolic and physiologic effects of rhEPO in anemic cancer patients
  • Effects of rhEPO on quality of life in anemic cancer patients
  • Thrombosis during therapy with erythropoiesis stimulating agents in cancer
  • The effect of rhEPO on survival in anemic cancer patients
  • From bench to bedside: Neuroprotective effects of erythropoietin
  • rhEPO in patients with anemia and congestive heart failure
  • Cost-effectiveness of treating cancer anaemia.